Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region.

According to the Cholesterol Treatment Trialists’ Collaboration, more-intensive statin regimens produce a highly significant 15% further reduction in major vascular events compared to less intensive regimens, primarily through significant reductions in coronary death and non-fatal myocardial infarction ( Cholesterol Treatment Trialists CTT Collaboration et al., 2010 ).

also in 132,142 other papers